Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143556 |
| CAS No | 2761668-93-1 |
| Mol.F. | C20H19N3OS2 |
| Mol.Wt. | 381.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143557 |
| CAS No | NA |
| Mol.F. | C12H13N4O5S : Na |
| Mol.Wt. | 325.3 : 23.0g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143558 |
| CAS No | NA |
| Mol.F. | C12H14N4O5S |
| Mol.Wt. | 326.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143559 |
| CAS No | NA |
| Mol.F. | C14H18N2O2 |
| Mol.Wt. | 246.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143560 |
| CAS No | NA |
| Mol.F. | C12H12N4O3 |
| Mol.Wt. | 260.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143561 |
| CAS No | NA |
| Mol.F. | C11H9N5O4 |
| Mol.Wt. | 275.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143562 |
| CAS No | NA |
| Mol.F. | C14H21N3O |
| Mol.Wt. | 247.34 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0143563 |
| CAS No | NA |
| Mol.F. | C6H10N2O2 |
| Mol.Wt. | 142.16 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143564 |
| CAS No | NA |
| Mol.F. | C13H17N5O |
| Mol.Wt. | 259.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143565 |
| CAS No | 111348-65-3 |
| Mol.F. | C5H12N2O3 |
| Mol.Wt. | 148.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143566 |
| CAS No | NA |
| Mol.F. | C11H14N2O2 |
| Mol.Wt. | 206.24 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0143567 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143568 |
| CAS No | 2114-63-8 |
| Mol.F. | C15H14N2O3 |
| Mol.Wt. | 270.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143569 |
| CAS No | 60096-51-7 |
| Mol.F. | C6H10N2O4 |
| Mol.Wt. | 174.2 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143570 |
| CAS No | 6335-95-1 |
| Mol.F. | C7H9N3O |
| Mol.Wt. | 151.17 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143571 |
| CAS No | NA |
| Mol.F. | C12H17N3O5 |
| Mol.Wt. | 283.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |